Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Specialty pharmaceuticals company SciClone taken private by investor consortium

Executive Summary

SciClone Pharmaceuticals Inc. (specialty pharmaceuticals) agreed to be acquired by Silver Biotech Investment Limited, an investor consortium consisting of GL Capital Management, Bank of China Group, CDH Investments, Ascendent Capital Partners and Boying for $11.18 per share (16.1% premium) in cash or approximately $605mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Buy-out
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register